Immunic, Inc. (IMUX),a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the appointment of Barclay "Buck" A.Phillips, an established life sciences executive, investor and entrepreneur, to its Board of Directors, effectiveNovember 14, 2019...

SAN DIEGO,Oct. 15, 2019/PRNewswire/ --Immunic, Inc. (Nasdaq:IMUX),a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the appointment ofTamar Howson, a highly seasoned life sciences executive, to its Board of Directors...